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Disruption of FOXP2, a gene encoding a forkhead-
domain transcription factor, causes a severe develop-
mental disorder of verbal communication, involving
profound articulation de®cits, accompanied by linguistic
and grammatical impairments. Investigation of the
neural basis of this disorder has been limited previously
to neuroimaging of affected children and adults. The
discovery of the gene responsible, FOXP2, offers a
unique opportunity to explore the relevant neural mech-
anisms from a molecular perspective. In the present
study, we have determined the detailed spatial and
temporal expression pattern of FOXP2 mRNA in the
developing brain of mouse and human. We ®nd expres-
sion in several structures including the cortical plate,
basal ganglia, thalamus, inferior olives and cerebellum.
These data support a role for FOXP2 in the develop-
ment of corticostriatal and olivocerebellar circuits
involved in motor control. We ®nd intriguing concord-
ance between regions of early expression and later sites
of pathology suggested by neuroimaging. Moreover, the
homologous pattern of FOXP2/Foxp2 expression in
human and mouse argues for a role for this gene in
development of motor-related circuits throughout mam-
malian species. Overall, this study provides support for
the hypothesis that impairments in sequencing of move-
ment and procedural learning might be central to the
FOXP2-related speech and language disorder.
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Introduction
Despite signi®cant advances in understanding of human brain
function during the past few decades, it has not yet been
possible to elucidate the precise neural mechanisms that have
gone awry in developmental learning disorders such as
speech and language impairment, dyslexia and autism.
Research into the neural bases of such disorders initially
was limited to neuroanatomical studies of post-mortem
material (e.g. Bauman and Kemper, 1985; Galaburda et al.,
1985; Cohen et al., 1989). More recently, the development of
less invasive techniques has allowed extensive in vivo
structural and functional neuroimaging of affected children
and adults (e.g. Bailey et al., 1998; Clark et al., 1998;
Shaywitz et al., 1998; Eckert et al., 2003). However, it has not
been feasible previously to investigate the neural mechanisms
underlying language-related disorders using the powerful
tools of molecular biology. The discovery of FOXP2, the ®rst
case of a gene that is implicated in a developmental disorder
of speech and language (Lai et al., 2001), now provides a
unique opportunity to explore relevant neural pathways from
a molecular perspective.
The link between FOXP2 and speech and language de®cits
was uncovered by molecular studies of an unusual three-
generation family, referred to as KE (Fisher et al., 1998; Lai
et al., 2000, 2001). Half of the members of this family (15
individuals) suffer from a severe disorder, involving profound
de®cits in the control of complex coordinated face and mouth
movements, resulting in disrupted speech (Hurst et al., 1990;
Vargha-Khadem et al., 1998). This persistent orofacial
Brain 126 ã Guarantors of Brain 2003; all rights reserved
DOI: 10.1093/brain/awg247 Advanced Access publication July 22, 2003 Brain (2003), 126, 2455±2462
 at M
ain Library L610 Lawrence Liverm







dyspraxia has its onset early in childhood and is later
accompanied by impairments in the development of a wide
range of linguistic and grammatical skills (Watkins et al.,
2002a). Such impairments are evident in both expressive and
receptive domains, whether assessed by oral or written means
(Watkins et al., 2002a). Although the mean non-verbal
intelligence of affected family members is lower than that of
unaffected members (Vargha-Khadem et al., 1995), the
disorder does not simply represent a general intellectual
delay (Watkins et al., 2002a). A detailed review of the
relationship between the various aspects of the KE phenotype
is given by Fisher et al. (2003).
Unlike the vast majority of families affected with develop-
mental speech and language disorders, the inheritance pattern
in the KE family is compatible with mutation of a single
autosomal dominant locus. Using linkage analysis, the
mutated gene was mapped to chromosome 7q31 (Fisher
et al., 1998). Further studies revealed the presence of a point
mutation in FOXP2 in all affected KE family members, but in
no unaffected members (Lai et al., 2001). This same gene was
directly disrupted by a chromosomal rearrangement in an
unrelated individual (C.S.) who had a similar phenotype to
that found in affected KE subjects.
FOXP2 encodes a novel forkhead transcription factor.
These proteins are de®ned by the presence of a forkhead-box
DNA-binding motif, and they regulate expression levels of
target genes during signal transduction, cellular differenti-
ation and pattern formation (Carlsson and Mahlapuu, 2002).
Many have key functions in tissue patterning during
embryogenesis, and mutations of different forkhead genes
are known to cause a variety of developmental disorders,
including glaucoma (Nishimura et al., 1998), immune
de®ciency (Wildin et al., 2001) and ovarian failure
(Crisponi et al., 2001). The mutation in affected KE
individuals alters an amino acid in a critical position of the
forkhead domain of FOXP2, which is likely to have adverse
consequences for protein function.
Current understanding of the neurological aspects of the
disorder associated with FOXP2 disruption is based largely
on neuroimaging studies (Vargha-Khadem et al., 1998;
Watkins et al., 2002b; Belton et al., 2003). MRI and
PET have revealed several abnormal brain structures in
affected KE family members, compared with unaffected
controls. These include the caudate nucleus of the basal
ganglia, which is bilaterally abnormal both structurally and
functionally. Given that insuf®cient functional FOXP2 during
embryogenesis is a likely cause of the problems of family KE
and case C.S., we may gain new aetiological insights by
studying the FOXP2 expression pattern in the developing
brain.
Previously, limited data on Foxp2 expression in mouse
embryos have been reported. Shu et al. (2001) showed that
Foxp2 is expressed in areas of the developing lungs, the
intestinal system and the cardiovascular system. They also
reported that Foxp2 mRNA can be detected in the
interneurons of the spinal cord at gestational day 12.5
(E12.5), and in the inner intermediate zone of neopallial
cortex at E16.5. In humans, FOXP2 mRNA has been detected
in brain tissue from adults and fetuses using northern blot
analysis (Lai et al. 2001), and in the caudate nucleus of adults
using reverse transcriptase±polymerase chain reaction (RT±
PCR) (Bruce and Margolis, 2002). Nevertheless, these
previous studies did not acquire detailed knowledge on the
temporal and spatial expression of FOXP2 during early brain
development in either mouse or human. Therefore, in the
present study, we have determined the pattern of Foxp2/
FOXP2 mRNA distribution during embryonic and fetal
development of the CNS in both species. We suggest that
integration of these data with results from neuroimaging
studies brings us closer towards a coherent explanation of the
pathogenesis of this speech and language disorder.
Material and methods
Embryonic/fetal material
Foxp2 expression was characterized in random-bred CD1
mouse brain at E11.5, E13.5, E16.5 and in newborns. The
distribution of FOXP2 mRNA was studied in the human brain
at Carnegie stage (CS) 17, 18, 19, 21 and 23, and fetal stage
(FS) 1 (O'Rahilly and MuÈller, 1987). Human embryonic/fetal
material was obtained from the MRC/Wellcome Trust
Human Developmental Biology Resource with full ethical
approval.
Production of plasmids with Foxp2/FOXP2
inserts
Two regions of Foxp2/FOXP2 were ampli®ed by PCR using
multiple-tissue cDNA panels (Clontech). These regions were
chosen for their low homology to Foxp1/FOXP1, a closely
related forkhead gene (Shu et al., 2001; Banham et al., 2001).
The primers used were: Foxp2 (mouse) middle probe (5¢±
3¢) AATGGATCCCTGCTCAGCCTTCAGC and (3¢±5¢)
AATGGATCCAGACGTTCGCGTTCC, generating a 509 bp
product spanning exons 6±10; Foxp2 3¢ probe (5¢±3¢)
AATGGATCCAGTTTGGGCTATGGAGC and (3¢±5¢)
AATGGATCCGCCTGTTGGTTCTGAATC, generating a
521 bp product spanning exons 15±17; FOXP2 (human)
middle probe (5¢±3¢) AATGGATCCCATCTGCTCAGCC-
TTC and (3¢±5¢) AATGGATCCGAAGACGTTCGCGTTC,
generating a 514 bp product spanning exons 6±10; and
FOXP2 3¢ probe (5¢±3¢) AATGGATCCTGGCTCTTAA-
GGGTTC and (3¢±5¢) AATGGATCCAGCTCTTGGCCA-
TGG, generating a 551 bp product containing untranslated
sequence from exon 17.
PCR products were cloned into pBlueScript-KS
(Stratagene), using BamHI restriction sites incorporated into
the primers. Insert sequences and orientations were con®rmed
by automated sequencing (Applied Biosystems).
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Generation of Foxp2/FOXP2 riboprobes
Antisense and sense probes were generated by in vitro
transcription using T7 and Sp6 RNA polymerases under
standard procedures. Digoxigenin-dUTP was incorporated
into riboprobes during in vitro transcription by using the DIG
RNA labelling mix (Roche) according to the manufacturer's
instructions.
In situ hybridization
In situ hybridization was carried out as described by
Wilkinson (1992). Brie¯y, embryos/fetuses at selected stages
were dissected and ®xed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) overnight at 4°C. Following
®xation, tissues were dehydrated and embedded in paraf®n
wax. Sections of 8±10 mm were cut using a standard
microtome and attached to slides coated with 3-aminopropyl-
triethoxysilane or Superfrost Plus microscopic slides (BDH).
Before hybridization, tissue sections were de-waxed,
hydrated, ®xed in 4% PFA/PBS and rinsed twice with PBS.
Proteins were removed by incubation with proteinase K
(20 mg/ml) in PBS. After washing with PBS, the sections were
re-®xed in the same PFA solution, and treated with 0.1 M
triethanolamine containing 0.25% acetic anhydride. Slides
were dehydrated through an alcohol series and air-dried.
Hybridization solution contained riboprobe (1/100 dilu-
tion), RNAguard (1 ml/ml) and tRNA (0.5 mg/ml) in
hybridization buffer (50% formamide, 0.3 M NaCl, 20 mM
Tris±HCl pH 7.5, 5 mM EDTA pH 8.0, 10% dextran sulfate
and 13 Denhardt's solution). A 100 ml aliquot of hybridiz-
ation probe was added to each slide, which was incubated in a
sealed chamber moistened with 50% formamide/1 3 standard
saline citrate (SSC) overnight at 65°C.
Stringency washes were performed in the following order:
23 SSC (twice at 65°C); 50% formamide/23 SSC (twice at
65°C); 23 SSC (twice at 65°C); 0.23 SSC (65°C) and 0.23
SSC (65°C cooled to room temperature). Slides were then
incubated for 1 h in 150 mM NaCl and 100 mM Tris±HCl
pH 7.5 containing 10% fetal calf serum (FCS). For antibody
detection, slides were incubated in anti-digoxigenin antibody
conjugated with alkaline phosphatase (anti-Dig antibody
diluted 1 : 1000, containing 2% FCS) overnight at 4°C.
Expression patterns were visualized using the NBT/BCIP
system (Roche). Sections were mounted in VectaMount
(Vector Labs) and analysed using the Axioplan 2 imaging
system (Zeiss). Hybridization experiments were repeated in
at least three mouse embryos and one human embryo at each
developmental stage.
Results
We characterized Foxp2/FOXP2 expression in mouse brain at
E11.5±E16.5 and newborn, and in human brain at CS17±23
and FS1, as described in Material and methods. Two probes
from different areas of Foxp2/FOXP2 were used, with
identical results in each case.
We ®rst observed Foxp2 expression in the developing
mouse brain at E11.5 in the myelencephalic part of the
rhombencephalon, an area destined to form the future
medulla oblongata (data not shown). While no signal was
detected in human brain at CS17 (~41 days gestation),
FOXP2 mRNA was identi®ed at the midline of the hindbrain
by CS18 (~45 days gestation) (data not shown), with an
expression domain similar to that in mouse. This indicated
high conservation of timing and tissue distribution at onset of
Foxp2/FOXP2 transcription in the CNS of the two species. As
development progressed to the mid±late embryonic period,
Foxp2/FOXP2 expression became more complex, with
signals detected in several brain regions (Fig. 1). At E13.5/
CS23, expression was detected at the medullary raphe and in
con®ned areas of the medulla oblongata (Fig. 1H and I).
Strong signals were also localized to the alar plate of the
cerebellar primordium (Fig. 1A and B). In the diencephalon,
in situ hybridization labelled the medial region of the
hypothalamus and the thalamus, in both mouse and human
(Fig. 1C±E). A diffuse signal was found in the caudate
nucleus, adjacent to the internal capsule (Fig. 1F and G). The
expression pattern in human continued to strongly resemble
that in mouse.
Despite an increase in relative strength of hybridization
later in development, at E16.5 in mouse (Fig. 2) and FS1 in
human (Fig. 3), the basic neural structures positive for Foxp2/
FOXP2 expression remained unchanged. In mouse at E16.5,
signals became stronger in the hypothalamus and thalamus
(Fig. 2E, F, I and J). Foxp2 expression in the caudate±
putamen was more intense compared with that observed at
E13.5 (Fig. 2I and J). In the hindbrain, hybridization signal
was observed in the developing cerebellum, including the
deep nuclei (Fig. 2A and B). While the signal in the medulla
remained strong (Fig. 2M and N), Foxp2 transcripts were also
found at E16.5 in the substantia nigra (Fig. 2F), the inferior
colliculus, the habenular nucleus, the lateral lemniscus
nucleus and the zona incenta (data not shown).
FOXP2 transcription was found correspondingly in the
cerebellum, thalamus, caudate nucleus and medulla (Fig. 3) in
transverse sections through a human brain at FS1. Compared
with the pattern at CS23, an increase in both the intensity and
the extent of the FOXP2 expression domain in the thalamus
was observed. Hybridization in the caudate nucleus was weak
but detectable (Fig. 3D). Intense staining was still seen in the
cerebellum (Fig. 3E and F) at FS1, while an equally
prominent signal was located in the developing inferior
olivary nuclei of the medulla (Fig. 3G and H).
Due to ethical limitations and restricted availability of
material, studies of human embryonic expression were
con®ned to early gestation; data from later gestation were
obtained only for mouse. In newborn mice, the majority of
neural structures are in their mature form and readily
identi®able. Strong Foxp2 signal was seen in the piriform
layer of the cerebellum (Fig. 2C and D), which consists of
large Purkinje cells. Weaker staining was found in the caudate
nucleus (Fig. 2K and L), the cortical plate (Fig. 2K and L), the
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substantia nigra (data not shown) and a number of thalamic
nuclei (Fig. 2G and H). Transcription of Foxp2 was also
detected in the inferior colliculus and the lemniscus nuclei
(data not shown). At this stage, the distinctive expression seen
in the medulla oblongata at E13.5/E16.5 could be clearly
identi®ed as the developing inferior olives (Fig. 2O and P),
homologous to the expression pattern observed in human.
Discussion
Our detailed study of Foxp2/FOXP2 mRNA distribution
during development of the mammalian CNS indicates that the
gene is not uniformly or diffusely expressed, but neither is its
expression limited to just one brain area. Instead, we ®nd that
it shows restricted expression in a number of related brain
structures. It is of note that there are many brain regions in
which we did not detect FOXP2 expression, including the
developing and mature hippocampus. Moreover, as the brain
matures, FOXP2 expression is re®ned to speci®c substruc-
tures within positive regions. For example, early diffuse
expression in the medulla becomes con®ned to the inferior
olives, while cerebellar expression is restricted to the piriform
layer by the time of birth. Thus, FOXP2 transcription appears
to be tightly regulated both spatially and temporally during
CNS development.
FOXP2 is expressed in motor-related circuits
during brain development
In addition to expression in the developing cortical plate,
FOXP2 transcription during CNS development is found
predominantly in a series of neural circuits that have been
implicated in motor control, including the basal ganglia, the
thalamus, the inferior olives and the cerebellum. These
structures are intricately interconnected to subserve motor-
related functions; the basal ganglia modulate activity of
premotor and prefrontal cortical areas via complex connec-
tions projecting through the globus pallidus, substantia nigra
and thalamus, while the cerebellum plays an important role in
regulating motor coordination, receiving input from the
inferior olives. Our data implicating FOXP2 in the develop-
ment of corticostriatal and olivocerebellar motor-related
circuits during embryogenesis may account for the persistent
oromotor problems of humans with FOXP2 mutation
(Vargha-Khadem et al., 1998).
It is possible that the accompanying linguistic and gram-
matical impairments observed in the KE family are secondary
consequences of basic de®cits in motor planning and
sequencing. However, it is equally plausible that the motor
and cognitive problems arise simultaneously. There is
growing appreciation that areas traditionally considered to
be purely motor related also contribute to cognitive and
complex behaviour (Middleton and Strick, 2000). The
exclusively motoric nature of the caudate nucleus is chal-
lenged by data supporting roles in procedural learning and
memory (Packard and Knowlton, 2002). Similarly, it is now
recognized that the cerebellum and prefrontal cortex form
neural circuits with both motor and cognitive capabilities
(Diamond, 2000). Thus, our data are consistent with the
emerging view that subcortical structures play a signi®cant
role in linguistic functioning.
Fig. 1 Localization of Foxp2/FOXP2 by in situ hybridization in the developing mouse brain at E13.5 and in a human brain at a
comparable embryonic stage (CS23). (A±I) Transverse sections hybridized with an antisense probe generated from the 3¢-untranslated
regions of Foxp2/FOXP2. (A) In mouse, an intense hybridization signal is detected in the alar plate of the developing cerebellum. A
weaker signal is also observed in the mantle layer of the midbrain. (B) A very similar expression pattern in the early cerebellum is seen in
a corresponding section from a human brain at CS23. (C±E) In the mouse (C) and the human (D and E) diencephalon, the mamillary area
of the hypothalamus and the dorsal thalamus are labelled by the in situ hybridization technique. (F and G) Diffuse signal is found in the
caudate nucleus, adjacent to the internal capsule in both species. (H and I) In the mouse and human hindbrain, Foxp2/FOXP2 transcripts
are detected in the medullary raphe (arrows) and the medulla oblongata. (J) No signal is seen in the hybridizations performed with a 3¢
sense control to human. A similar result was obtained with mouse sense controls (data not shown). AP = alar plate; MB = midbrain;
H = hypothalamus; Th = thalamus; CN = caudate nucleus; IC = internal capsule; ME =medulla oblongata. Scale bars: (A, C, F and H)
1 mm, (B, D, E, G, I and J) 0.5 mm.
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Fig. 2 Foxp2 mRNA expression in the embryonic mouse brain at E16.5 and in the newborn. Sequential transverse sections, from anterior
to posterior, hybridized with antisense Foxp2 3¢ probe, are shown in the ®rst and the third columns. Boxed areas are shown magni®ed in
adjacent panels. (A±D) Strong Foxp2 signal is observed in the cerebellum at E16.5 (A and B) with restriction in the newborn to the
piriform layer, but not the molecular layer or the granular layer (C and D). (E±L) Foxp2 is strongly expressed in the thalamus at E16.5
and in the newborn. Various thalamic nuclei express Foxp2 (E, F, I and J), including the periventricular thalamic nuclei, ventral posterior
thalamic nucleus, posterior thalamic nucleus and the lateral dorsal thalamic nucleus (data not shown). Additionally, the medial geniculate
body and the dorsal lateral geniculate body show conspicuous Foxp2 staining. Foxp2 mRNA is also detected at the dorsalmedial
hypothalamic nucleus, the substantia nigra and the lateral lemniscus (data not shown). (G and H) Intense Foxp2 signal is seen in the
thalamus of the newborn. High intensity Foxp2 mRNA can be detected in the centromedial thalamic nucleus, the ventral posterior
thalamic nucleus and the ventromedial thalamic nucleus. (I±L) Besides the thalamus, Foxp2 mRNA is detected at both E16.5 and in the
newborn in the caudate nucleus, and expression is present in the developing cortical plate. In posterior brain sections of the newborn,
Foxp2 expression in the substantia nigra and lateral lemniscus can be identi®ed (data not shown). (M and N) Foxp2 expression in the
medulla oblongata is intense at E16.5. (O and P) In the newborn, this domain of Foxp2 expression is localized to the inferior olivary
complex (IO). CB = cerebellum; pl = piriform layer; ml = molecular layer; gl = granular layer; pvt = periventricular thalamic nucleus;
vpl = ventral posterior thalamic nucleus (lateral); pot = posterior thalamic nucleus; mg = medial geniculate body; dlg = dorsal lateral
geniculate body; dmt = dorsalmedial hypothalamic nucleus; SN = substantia nigra; cmt = centromedial thalamic nucleus; vpm = ventral
posterior thalamic nucleus (medial); vmt = ventromedial thalamic nucleus; CN = caudate nucleus; CP = cortical plate; IO = inferior
olivary complex. Scale bars: (A, C, E, G, I, K, M and O) 1 mm, (B, D, F, H, J, L, N and P) 0.5 mm.
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FOXP2 expression in sites of pathology
identi®ed by brain imaging
Previous studies of the neuroanatomical basis of the disorder
in the KE family have been necessarily limited to brain
imaging analyses (Vargha-Khadem et al., 1998; Watkins
et al., 2002b; Belton et al., 2003). Such investigations have
yielded insight into structural and functional neural abnorm-
alities that ultimately result from FOXP2 mutation, but are
unable to shed light on the developmental course that has led
to these abnormalities. The situation is complicated by
compensatory reorganization of abnormal neural systems,
and it is often dif®cult to determine the relationship between
the size of a neural structure, variation in its activation and its
overall contribution to disorder (Watkins et al., 2002b). By
highlighting regions of normal FOXP2 expression, we offer
the ®rst glimpse of how disruption of this gene might impact
on development of particular brain systems in the human
embryo.
There is an intriguing level of concordance between
structures implicated by our study and those suggested by
complementary investigations of affected individuals with
FOXP2 mutation. Most notably, our observation of FOXP2
expression in the developing caudate nucleus of the embryo is
paralleled by neuroimaging ®ndings in the KE family. A
bilateral reduction of grey matter density in the caudate
nucleus has been found in affected individuals using
morphometric and volumetric techniques (Vargha-Khadem
et al., 1998; Watkins et al., 2002b; Belton et al., 2003). In
addition, a PET study detected over-activation of the caudate
nucleus in two affected individuals when performing a word
repetition task (Vargha-Khadem et al., 1998). The converg-
ence of molecular, structural and functional data strengthens
the case that the caudate nucleus is an important site of
pathology in this disorder.
The caudate nucleus is not the sole site of FOXP2
expression, and it is also not the only region of abnormality
uncovered by neuroimaging studies of the KE family. For
example, FOXP2 mutation is also associated with signi®cant
structural anomalies in the cerebellum (Vargha-Khadem
et al., 1998; Watkins et al., 2002b; Belton et al., 2003), a
structure in which we have found striking FOXP2 expression
during embryonic development. Studies of unrelated patients
with acquired lesions have highlighted a cerebellar role in
procedural learning, particularly in detection and generation
of event sequences (Molinari et al., 1997), and in linguistic
functions (Schmahmann and Sherman, 1998). Indeed,
impairments in the ability to sequence movement or in
procedural learning recently were proposed as potential core
de®cits underlying the KE phenotype (Watkins et al., 2002a).
In addition to the Purkinje cells of the cerebellum, high
levels of FOXP2 mRNA were detected in the developing
inferior olives of the medulla. The climbing ®bres of inferior
olivary neurons provide strong synaptic excitation to the
Purkinje cells, forming a system that plays an important role
in coordination and timing of motor control (Welsh et al.,
1995; Yarom and Cohen, 2002). In relation to this, it has been
reported that affected KE subjects are de®cient in perception
and production of rhythm, both vocally and manually (Alcock
et al., 2000). Our expression data, therefore, draw attention to
a possible link between the olivocerebellar system and timing
de®cits in the KE family, highlighting a neural circuit that
warrants further examination.
Fig. 3 FOXP2 mRNA expression pattern in human brain at FS1 (~9 weeks post-fertilization). (A, E and G) Sequential transverse sections
of the fetal brain. Boxed areas are shown magni®ed in adjacent panels (B, D, F and H). FOXP2 expression is observed in the tectum (B)
and the thalamus (C). (D) The caudate nucleus and the putamen of the basal ganglia are also positive for FOXP2 expression. (E and F)
Bilateral signal is observed in the cerebellum, in concordance with the pattern of mouse Foxp2 expression. (G and H) Intensive staining
in the medulla labels the developing inferior olivary nuclei. CN = caudate nucleus; Th = thalamus; CB = cerebellum; IO = inferior olivary
complex; Tm = tectum; CT-f = cortico-thalamic tract. Scale bars: (A, E and G) 1 mm, (B±D, F and H) 0.5 mm.
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FOXP2 expression patterns are highly
concordant in mouse and human brain
development
A key ®nding of our study is the high degree of similarity
between mouse and human FOXP2 expression patterns in the
developing CNS. We have not found any evidence for regions
of FOXP2 expression that are only observed in humans in
early brain development. Despite the high level of FOXP2
coding sequence conservation in mammals, evolutionary
studies indicate that human-speci®c changes in FOXP2
protein sequence underwent positive selection recently in
human history, at a time that is compatible with the
emergence of spoken language (Enard et al., 2002). Our
data suggest that FOXP2 might be generally implicated in
aspects of motor control in mammalian species, and was
already playing a role in the development of motor-related
brain regions in the human±mouse common ancestor. Thus,
positive selection of FOXP2 protein changes in recent human
history probably involved modi®cations to pre-existing brain
systems, rather than acquisition of novel ones.
Towards an integrated explanation of speech
and language disorder aetiology
In conclusion, our study demonstrates the potential of
integrating molecular genetic data with those obtained from
other approaches, including neuropsychological investiga-
tions and brain imaging. We provide evidence, from the
perspective of developmental biology, for involvement of the
caudate nucleus, thalamus, inferior olives and cerebellum in
the FOXP2-associated speech and language disorder. Future
work, including mouse models in which the Foxp2 gene is
disrupted, should provide additional insight into the role of
this gene in development of speci®c brain regions.
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